Wyckoff Heights Medical Center goes live with Sunrise EHR

Sunrise™ Acute Care, Sunrise™ Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM Sunrise™ Pharmacy now deployed, as well Allscripts patient engagement platform, FollowMyHealth®; extends and expands Managed Services engagement

CHICAGO–(BUSINESS WIRE)–Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that client Wyckoff Heights Medical Center is now live on its Sunrise™ platform, which includes Sunrise™ Acute Care, Sunrise Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM and Sunrise™ Pharmacy as well as Allscripts patient engagement platform, FollowMyHealth®.

Wyckoff Heights Medical Center provides care with kindness. More than 250,000 patient visits for acute, emergency, and surgical services and ambulatory care at locations on the border of Brooklyn and Queens, New York. The organization uses the integrated suite of Allscripts Sunrise solutions which supports the transition to value-based care and to improve clinical decision support. The medical center also recently purchased CarePort™, Allscripts care coordination suite of solutions to help ensure smooth transitions of care across the entire care continuum.

We selected the Sunrise comprehensive platform to help us drive better care delivery while promoting high levels of patient satisfaction and lowered clinician burnout,” says Ramon Rodriguez, President and CEO of Wyckoff Heights Medical Center. “Our partnership with Allscripts has proved successful and we look forward to seeing results across our entire system. No transition between platforms is without challenges and ours have benefited from the commitment of our Wyckoff staff and the excellent support of the Allscripts crew of onsite advisors. As a customer, I am very satisfied with Allscripts commitment to our needs for customization and on-site learning.”

Used by many of the leading hospitals and health systems in the world, Sunrise is a highly configurable solution that offers clinician-specific workflows that help drive adoption of clinical decision support that leads to improved outcomes. Wyckoff Heights Medical Center is Allscripts first client in New York State to go live on the entire Sunrise™ Financial Manager platform, which will enable the organization to meet the applicable New York state regulatory requirements.

With the Sunrise suite of solutions, Wyckoff Heights Medical Center has put the organization, its clinicians and, most importantly, its patients in a great position for significantly improved outcomes,” CEO Paul Black says. “Our partnership will continue to yield great results for the Wyckoff Heights community.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

Staff

Recent Posts

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

13 mins ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

14 mins ago

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by…

14 mins ago

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading…

14 mins ago

SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results

Sioux Falls, SD , March 29, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics Reports Full Year…

14 mins ago

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to May 3, 2024

MIAMI, March 29, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW)…

14 mins ago